Replies to post #40552 on Humanigen Inc (HGENQ)

[cowtown jay]

I find what the Item 5.02 DOESN'T say, more curious than what it does say. There was none of the language expected when announcing the departure of a Chief officer of the company. I was so curious that I looked at the Baudax filings the day before Ed resigned, to see if there was a clue provided. There was none that I could see.

The catalysts that can propel us forward are in place and active. There's no denying how effective lenz has shown to be in CMML and covid. Nothing is going to erase lenzilumab's demonstrated performance.

I just don't want any corporate actions undertaken to delay our reward. More importantly, I don't want any more regulatory inaction to delay our reward.